RecruitingPHASE1, PHASE2NCT07183384

MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universitas Padjadjaran
Principal Investigator
Akhmad Y Pramatirta, M.D., Ph.D
Dr. Hasan Sadikin Central General Hospital
Intervention
Mesenchymal Stem Cell-Derived Exosomes(biological)
Enrollment
80 target
Eligibility
18-50 years · FEMALE
Timeline
20242026

Study locations (1)

Collaborators

Dr. Hasan Sadikin General Hospital, Bandung, Indonesia · Dr Cipto Mangunkusumo General Hospital · Dr. Sardjito Hospital, Yogyakarta

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07183384 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials